News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
668,570 Results
Type
Article (32528)
Company Profile (178)
Press Release (635857)
Multimedia
Podcasts (54)
Webinars (10)
Section
Business (210270)
Career Advice (713)
Deals (31509)
Drug Delivery (82)
Drug Development (73265)
Employer Resources (54)
FDA (15381)
Job Trends (12901)
News (312392)
Policy (29123)
Tag
2025 Best Places to Work (11)
2026 Best Places to Work (19)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (6)
2027 Biotech Beach Standard (4)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Digital (1)
2027 Pharm Country Standard (1)
40 Under 40 (2)
Academia (2035)
Accelerated approval (51)
ADA (41)
Adcomms (15)
Allergies (194)
Alliances (44258)
ALS (219)
Alzheimer's disease (1664)
Antibody-drug conjugate (ADC) (537)
Approvals (16289)
Artificial intelligence (674)
ASCO (272)
Autoimmune disease (401)
Automation (44)
Bankruptcy (325)
Belgium (22)
Best Places to Work (10193)
BIO (54)
Biologics (88)
BIOSECURE Act (7)
Biosimilars (195)
BioSpace Insights (87)
Biotechnology (104)
Bispecific (55)
Bladder cancer (228)
Brain cancer (73)
Breast cancer (819)
Cancer (6412)
Cardiovascular disease (476)
Career advice (628)
Career pathing (21)
CAR-T (314)
CDC (41)
CDMO (85)
Celiac Disease (7)
Cell-line development (1)
Cell therapy (829)
Cervical cancer (58)
Clinical research (66921)
Collaboration (2067)
Commercialization (60)
Company closure (2)
Compensation (1719)
Complete response letters (60)
COVID-19 (1980)
CRISPR (105)
CRO (6)
C-suite (1307)
Cystic fibrosis (134)
Data (9699)
Decentralized trials (3)
Denatured (28)
Depression (176)
Dermatology (180)
Diabetes (668)
Diagnostics (6178)
Digital health (63)
Diversity (8)
Diversity, equity & inclusion (17)
Drug discovery (280)
Drug pricing (160)
Drug shortages (26)
Duchenne muscular dystrophy (285)
Earnings (85730)
Editorial (44)
Employer branding (6)
Employer resources (54)
ESMO (426)
Events (112520)
Executive appointments (1089)
Eye disease (17)
FDA (19980)
Fibrodysplasia Ossificans Progressiva (13)
Fragile X (4)
Friedreich's ataxia (27)
Frontotemporal dementia (31)
Funding (1655)
Gene editing (202)
Generative AI (46)
Gene therapy (604)
GLP-1 (843)
Government (3637)
Grass and pollen (4)
Guidances (401)
Healthcare (16943)
Hematology (184)
HIV (95)
Huntington's disease (61)
Idiopathic pulmonary fibrosis (14)
IgA nephropathy (125)
Immunology and inflammation (187)
Immuno-oncology (111)
Indications (265)
Infectious disease (2306)
Inflammatory bowel disease (231)
Inflation Reduction Act (13)
Influenza (128)
Intellectual property (326)
Interviews (82)
IPO (14715)
IRA (41)
Job creations (3081)
Job search strategy (576)
JPM (20)
Kidney cancer (25)
Kidney disease (145)
Labor market (62)
Layoffs (291)
Leadership (14)
Legal (7182)
Licensing (95)
Liver cancer (92)
Longevity (43)
Lung cancer (938)
Lung diease (21)
Lymphoma (482)
Machine learning (49)
Management (19)
Manufacturing (942)
Marketing (36)
MASH (195)
Medical affairs (5)
Medical device (14552)
Medtech (14878)
Mergers & acquisitions (18215)
Metabolic disorders (1478)
Middle East (2)
mRNA (177)
Multiple sclerosis (213)
Multispecific (3)
NASH (12)
Netherlands (23)
Neurodegenerative disease (414)
Neuropsychiatric disorders (88)
Neuroscience (3306)
Neurotech (3)
NextGen: Class of 2026 (5495)
Non-profit (3321)
Now hiring (52)
Obesity (576)
Opinion (148)
Ovarian cancer (257)
Pain (303)
Pancreatic cancer (360)
Parkinson's disease (378)
Partnered (29)
Patents (649)
Patient advocacy (7)
Patient recruitment (874)
Patient selection (99)
Peanut (64)
People (55645)
Peptides (33)
Pharmaceutical (40)
Pharmacy benefit managers (27)
Phase 1 (20713)
Phase 2 (29418)
Phase 3 (21787)
Pipeline (12597)
Policy (204)
Postmarket research (2407)
Preclinical (8327)
Press Release (46)
Prostate cancer (343)
Psychedelics (49)
Radioligand (2)
Radiopharmaceuticals (345)
Rare diseases (1066)
Real estate (4704)
Recruiting (21)
Regenerative medicine (29)
Regulatory (24340)
Reports (42)
Research institute (2000)
Resumes & cover letters (90)
Rett syndrome (55)
RNA editing (20)
RSV (74)
Saudi Arabia (1)
Schizophrenia (183)
Series A (280)
Series B (204)
Service/supplier (6)
Sickle cell disease (110)
Special edition (13)
Spinal muscular atrophy (154)
Sponsored (24)
Startups (3125)
Stem cells (5)
Stomach cancer (15)
Substance use disorders (21)
Supply chain (105)
Switzerland (15)
Tariffs (41)
Tax incentives (2)
The Weekly (26)
Vaccines (858)
Venture capital (57)
Weight loss (353)
Wet AMD (4)
Women's health (153)
Worklife (5)
Date
Today (55)
Last 7 days (786)
Last 30 days (3109)
Last 365 days (26516)
2026 (23960)
2025 (26171)
2024 (30877)
2023 (35308)
2022 (45825)
2021 (49658)
2020 (47784)
2019 (39147)
2018 (29517)
2017 (27675)
2016 (27181)
2015 (33488)
2014 (28574)
2013 (24265)
2012 (26565)
2011 (26957)
2010 (26072)
Location
Africa (533)
Alabama (96)
Alaska (4)
Arizona (423)
Arkansas (17)
Asia (34518)
Australia (5254)
California (15394)
Canada (4110)
China (1559)
Colorado (716)
Connecticut (652)
Delaware (452)
Europe (65148)
Florida (2353)
Georgia (510)
Hawaii (3)
Idaho (56)
Illinois (1290)
India (93)
Indiana (615)
Iowa (24)
Japan (670)
Kansas (134)
Kentucky (46)
Louisiana (56)
Maine (34)
Maryland (1812)
Massachusetts (10592)
Michigan (410)
Minnesota (846)
Mississippi (8)
Missouri (145)
Montana (28)
Nebraska (26)
Nevada (165)
New Hampshire (81)
New Jersey (4039)
New Mexico (20)
New York (3948)
North Carolina (1897)
North Dakota (8)
Northern California (7830)
Ohio (420)
Oklahoma (21)
Oregon (38)
Pennsylvania (2935)
Puerto Rico (31)
Rhode Island (60)
South America (767)
South Carolina (96)
South Dakota (1)
Southern California (6350)
Tennessee (252)
Texas (2593)
United States (53460)
Utah (469)
Vermont (1)
Virginia (331)
Washington D.C. (70)
Washington State (1223)
West Virginia (4)
Wisconsin (150)
Wyoming (3)
668,570 Results for "halt medical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Australian ALS therapy aimed at halting disease progression and restoring function advances to Phase 2 trial
November 10, 2026
·
3 min read
Press Releases
Australian therapy aimed at halting MND progression and restoring function advances to national Phase 2 trial
November 10, 2026
·
4 min read
ALS
Novartis halts TREM2 targeting ALS program in 4th
trial stumble in a month
The TREM2 stabilizer failed to show efficacy in a Phase 2 trial of patients with early-stage ALS. This development follows two late-stage trial failures reported by Novartis last week, plus the news that the pharma has paused multiple CAR T cell trials following patient deaths.
September 16, 2026
·
2 min read
·
Heather McKenzie
Cancer
BioNTech halts mid-stage trial of personalized mRNA vaccine in colorectal cancer
Shares of Germany-based BioNTech were down as much as 8% Friday after announcing a Phase 2 trial of autogene cevumeran would be discontinued for futility. The news follows Merck and Moderna’s Phase 3 win last week for their cancer vaccine plus Keytruda in melanoma.
August 28, 2026
·
2 min read
·
Heather McKenzie
Press Releases
Inventiva Announces Temporary Trading Halt of its Ordinary Shares on Euronext Paris
June 2, 2026
·
2 min read
Press Releases
Nanobiotix Announces Temporary Trading Halt of Its Ordinary Shares on Euronext Paris
May 21, 2026
·
2 min read
Insights
IPF draws investor heat as biotechs target fibrosis halt, better tolerability
Novel targets aim to stop lung scarring—where current drugs only slow it—while improving tolerability and unlocking fibrosis in other organs next
May 5, 2026
·
3 min read
·
Jennifer C. Smith-Parker
Press Releases
NorthStrive Fund II LP Calls on enVVeno Medical to Halt Clinical Spending Plans and Call Special Shareholder Meeting to Vote on Strategic Alternatives
March 3, 2026
·
1 min read
Vaccines
Pfizer, BioNTech Halt Large US COVID-19 Vaccine Trial Over Slow Enrollment
COVID-19 partners Pfizer and BioNTech have been unable to recruit healthy adults aged 50 to 64 fast enough to deliver relevant post-marketing data. Moderna is apparently also facing enrollment challenges.
April 2, 2026
·
2 min read
·
Nick Paul Taylor
Press Releases
Utah Medical Products, Inc. Increases Quarterly Dividend - November 3, 2026
November 3, 2026
·
1 min read
1 of 66,857
Next